0 items / CHF0.00

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

0 items / CHF0.00

xpovio

Click to enlarge

Previous product

<img width="600" height="600" src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/tukysa_1-600x600.png" class="attachment-woocommerce_thumbnail size-woocommerce_thumbnail" alt="" srcset="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/tukysa_1-600x600.png 600w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/tukysa_1-300x300.png 300w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/tukysa_1-150x150.png 150w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/tukysa_1.png 700w" sizes="(max-width: 600px) 100vw, 600px" />

Tukysa (tucatinib) CHF3,224.92

Back to products

Next product

<img width="600" height="600" src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-20_at_5.39.09_pm-600x600.png" class="attachment-woocommerce_thumbnail size-woocommerce_thumbnail" alt="" srcset="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-20_at_5.39.09_pm-600x600.png 600w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-20_at_5.39.09_pm-300x300.png 300w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-20_at_5.39.09_pm-150x150.png 150w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-20_at_5.39.09_pm.png 700w" sizes="(max-width: 600px) 100vw, 600px" />

Monjuvi (tafasitamab-cxix) CHF4,160.00

Xpovio (selinexor)

CHF32,825.00

Xpovio (selinexor) is a medication used for the treatment of patients with relapsed/refractory multiple myeloma or diffuse large B-cell lymphoma.

It has been approved by the European Medicines Agency (EMA) under the brand name Nexpovio (selinexor.

Add to wishlist

Category: Oncology

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Xpovio (selinexor)”

Start typing to see products you are looking for.

No account yet?

Create an Account